Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiongshao Zhitong Granules for migraine
CTR20261885Phase 2Active
- Sponsor
- Kaizhong Biotech
- Start
- May 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in migraine comparing xiongshao zhitong granules with placebo (2 arms). Started May 2026; status: active.
02
Drugs
xiongshao zhitong granules
03
Conditions
migraine
Beyond the preview
Go deeper on CTR20261885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261885.